JP2024511356A5 - - Google Patents
Info
- Publication number
- JP2024511356A5 JP2024511356A5 JP2023557020A JP2023557020A JP2024511356A5 JP 2024511356 A5 JP2024511356 A5 JP 2024511356A5 JP 2023557020 A JP2023557020 A JP 2023557020A JP 2023557020 A JP2023557020 A JP 2023557020A JP 2024511356 A5 JP2024511356 A5 JP 2024511356A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition according
- polynucleotide
- item
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162496P | 2021-03-17 | 2021-03-17 | |
| US63/162,496 | 2021-03-17 | ||
| PCT/US2022/020774 WO2022197940A1 (en) | 2021-03-17 | 2022-03-17 | Vaccine compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511356A JP2024511356A (ja) | 2024-03-13 |
| JP2024511356A5 true JP2024511356A5 (https=) | 2025-03-25 |
Family
ID=83320823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557020A Pending JP2024511356A (ja) | 2021-03-17 | 2022-03-17 | ワクチン組成物及びその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240156948A1 (https=) |
| EP (1) | EP4308129A4 (https=) |
| JP (1) | JP2024511356A (https=) |
| KR (1) | KR20230156945A (https=) |
| CN (1) | CN117279648A (https=) |
| AU (1) | AU2022239561A1 (https=) |
| BR (1) | BR112023018838A2 (https=) |
| CA (1) | CA3212387A1 (https=) |
| IL (1) | IL305819A (https=) |
| MX (1) | MX2023010807A (https=) |
| WO (1) | WO2022197940A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102832944B1 (ko) * | 2024-12-27 | 2025-07-15 | 대한민국 | 제2형 중증급성호흡기증후군 코로나바이러스 변이들의 공통 서열을 포함하는 코로나바이러스감염증-19 범용 백신 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1820020B (zh) * | 2003-05-06 | 2010-04-28 | 技术持有有限公司 | Sars-冠状病毒病毒样颗粒以及应用方法 |
| US7741022B2 (en) * | 2006-01-18 | 2010-06-22 | Wisconsin Alumi Research Foundation | Protein inhibitor of Ran activity and methods of use thereof |
| US20190382450A1 (en) * | 2018-06-18 | 2019-12-19 | University Of Maryland, College Park | Newcastle disease virus-based vectored vaccine |
| CN111748557B (zh) * | 2020-04-03 | 2022-03-11 | 苏州吉玛基因股份有限公司 | 抑制新型冠状病毒的小干扰核酸及组合物和应用 |
| US11130787B2 (en) * | 2020-06-11 | 2021-09-28 | MBF Therapeutics, Inc. | Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods |
-
2022
- 2022-03-17 AU AU2022239561A patent/AU2022239561A1/en not_active Abandoned
- 2022-03-17 WO PCT/US2022/020774 patent/WO2022197940A1/en not_active Ceased
- 2022-03-17 BR BR112023018838A patent/BR112023018838A2/pt not_active Application Discontinuation
- 2022-03-17 KR KR1020237035159A patent/KR20230156945A/ko active Pending
- 2022-03-17 EP EP22772215.4A patent/EP4308129A4/en active Pending
- 2022-03-17 CA CA3212387A patent/CA3212387A1/en active Pending
- 2022-03-17 MX MX2023010807A patent/MX2023010807A/es unknown
- 2022-03-17 IL IL305819A patent/IL305819A/en unknown
- 2022-03-17 CN CN202280028754.0A patent/CN117279648A/zh active Pending
- 2022-03-17 JP JP2023557020A patent/JP2024511356A/ja active Pending
-
2023
- 2023-09-13 US US18/466,251 patent/US20240156948A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512519A5 (https=) | ||
| Berglund et al. | Enhancing immune responses using suicidal DNA vaccines | |
| US9714272B2 (en) | Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom | |
| JP2004518631A5 (https=) | ||
| JP2023545009A5 (https=) | ||
| JP2020078318A5 (https=) | ||
| JP2006523224A (ja) | 免疫原性組成物および方法 | |
| JP2020518265A5 (https=) | ||
| CN113226364A (zh) | 组合物和方法 | |
| JP2024177497A5 (https=) | ||
| JP2023527083A5 (https=) | ||
| Schultz et al. | Update on antiviral DNA vaccine research (1998–2000) | |
| JP2023521662A5 (https=) | ||
| JP2023536570A5 (https=) | ||
| JP2024511356A5 (https=) | ||
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| JP2024523329A5 (https=) | ||
| CA2380716A1 (en) | Dna vaccine using liposome-encapsulated plasmid dna encoding for hemagglutinin protein of influenza virus | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| CN117771359A (zh) | 一种包含双佐剂的rsv疫苗、制备方法及其应用 | |
| JP4091152B2 (ja) | 金コロイドを含む核酸調製物 | |
| JP2025513827A5 (https=) | ||
| JP7314441B2 (ja) | 選択的ｃｄ８陽性ｔ細胞誘導ワクチン抗原 | |
| CN110234347A (zh) | 使用了非感染性副粘病毒粒子的传染病疫苗 | |
| JP2002544236A (ja) | 組換えパラポックスウイルスに基づくとりわけ肝の慢性ウイルス感染症ならびに炎症性、変性性および増殖性疾患ならびに癌のための器官、組織および細胞特異的免疫治療薬 |